Compare, Analyse Fulford India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs TEVA PHARMA (Israel) - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FULFORD INDIA   TEVA PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
TEVA PHARMA
Dec-13
FULFORD INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9422,965-   
Low Rs4502,576-   
Sales per share (Unadj.) Rs691.41,701.8-  
Earnings per share (Unadj.) Rs11.5106.3-  
Cash flow per share (Unadj.) Rs15.4243.9-  
Dividends per share (Unadj.) Rs2.0093.06-  
Dividend yield (eoy) %0.33.4 8.6%  
Book value per share (Unadj.) Rs380.01,890.4-  
Shares outstanding (eoy) m3.90848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.6 61.8%   
Avg P/E ratio x60.726.1 233.0%  
P/CF ratio (eoy) x45.311.4 398.9%  
Price / Book Value ratio x1.81.5 125.0%  
Dividend payout %17.487.5 19.9%   
Avg Mkt Cap Rs m2,7142,349,435 0.1%   
No. of employees `0000.444.9 1.0%   
Total wages/salary Rs m5050-   
Avg. sales/employee Rs Th6,073.032,108.3 18.9%   
Avg. wages/employee Rs Th1,137.40-   
Avg. net profit/employee Rs Th100.72,005.8 5.0%   
INCOME DATA
Net Sales Rs m2,6961,443,107 0.2%  
Other income Rs m1250-   
Total revenues Rs m2,8221,443,107 0.2%   
Gross profit Rs m-46395,196 -0.0%  
Depreciation Rs m15116,648 0.0%   
Interest Rs m1028,345 0.0%   
Profit before tax Rs m54250,203 0.0%   
Minority Interest Rs m01,137 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,244 0.0%   
Tax Rs m10-3,055 -0.3%   
Profit after tax Rs m4590,150 0.0%  
Gross profit margin %-1.727.4 -6.3%  
Effective tax rate %17.7-1.2 -1,448.1%   
Net profit margin %1.76.2 26.5%  
BALANCE SHEET DATA
Current assets Rs m1,738974,669 0.2%   
Current liabilities Rs m545849,994 0.1%   
Net working cap to sales %44.38.6 512.4%  
Current ratio x3.21.1 278.3%  
Inventory Days Days4891 53.4%  
Debtors Days Days496 4.5%  
Net fixed assets Rs m12471,350 0.0%   
Share capital Rs m393,552 1.1%   
"Free" reserves Rs m1,4430-   
Net worth Rs m1,4821,603,018 0.1%   
Long term debt Rs m0737,892 0.0%   
Total assets Rs m2,0773,297,961 0.1%  
Interest coverage x6.79.8 68.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.4 296.7%   
Return on assets %2.63.6 72.6%  
Return on equity %3.05.6 53.6%  
Return on capital %4.34.9 87.3%  
Exports to sales %00-   
Imports to sales %24.50-   
Net fx Rs m-6560-   
CASH FLOW
From Operations Rs m90229,956 0.0%  
From Investments Rs m105-81,483 -0.1%  
From Financial Activity Rs m-14-275,848 0.0%  
Net Cashflow Rs m181-127,375 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare FULFORD INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare FULFORD INDIA With: DR. DATSONS LABS  TORRENT PHARMA  PFIZER  VENUS REMEDIES  BIOCON   



Today's Market

Sensex Opens Higher; Consumer Durables and Energy Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 0.1%.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS